Among the eight genes, RGS2 was significantly correlated with the TMB and CD8+ T cell infiltration in GC, suggesting that RGS2 may be a potential target for future immunotherapy strategies toward GC (148). This evidence concerns the gene RGS2 and gastric cancer.